|Day Low/High||1.33 / 1.40|
|52 Wk Low/High||0.64 / 5.37|
Michael Castagna appointed Chief Executive Officer and Member of MannKind Board of Directors
Conference Call to Begin Today at 5:00 PM ET
Shares of insulin maker Mannkind plummeted on news of a proposed stock split, staffing changes and a new iteration of its insulin.
Mannkind stock is suffering, and the company appears to be in trouble.
Other movers included Mannkind, Perrigo and Bristol-Myers Squibb.
The stock has taken a beating, but users of Afrezza are loyal to the drug.
2016 tweets by TheStreet's Adam Feuerstein kept us informed and entertained. From an unexpected twist on New Year's day with MannKind to J.P. Morgan's Healthcare conference to Bristol-Myers Squibb's oops!
TheStreet's biotech columnist offers his own report card on biotech stocks.
A look back at the year's worth of Adam Feuerstein's biotech tweets.
Here's a technical look at how to trade several under-$10 stocks triggering breakout trades.
Donald Trump's victory may be a win for Wall Street traders; Colgate-Palmolive remains on slippery slope; and more from TheStreet and its various properties.